首頁 > 市場調查報告書 > 製藥

癌症

經尿道切除術(TURP) 市場規模、佔有率和成長分析：按產品類型、技術、應用、最終用戶和地區分類－2026-2033 年產業預測

市場調查報告書

商品編碼

1964201

經尿道切除術(TURP) 市場規模、佔有率和成長分析：按產品類型、技術、應用、最終用戶和地區分類－2026-2033 年產業預測

Transurethral Resection of The Prostate Market Size, Share, and Growth Analysis, By Product Type, By Technology, By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2026年02月18日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2024年全球經尿道前列腺切除術（TURP）市值為9.804億美元，預計將從2025年的10.3138億美元成長到2033年的15.4719億美元。預測期（2026-2033年）的複合年成長率預計為5.2%。

全球經尿道前列腺切除術(TURP) 市場的主要驅動力是人口老化（男性人口比例上升）和良性前列腺增生 (BPH) 盛行率的增加，這推動了對手術治療方法的需求。 TURP 是一種基礎內視鏡手術，旨在緩解尿路梗阻，並已成為標準治療方法，從而推動了相關設備的創新。隨著技術從單極系統發展到雙極系統和雷射切除，安全性的提高和併發症的減少促使醫療機構採用這些先進技術。此外，能量平台和手術全期工作流程的創新降低了風險並縮短了恢復時間，促進了 TURP 在臨床實踐中的廣泛應用。這導致門診手術量增加，使製造商能夠提供捆綁式耗材，並拓展新興市場。

全球經尿道前列腺切除術市場促進因素

隨著全球老化社會的加劇，良性攝護腺增生（BPH）及相關泌尿系統疾病的盛行率不斷上升，導致對經尿道前列腺切除術等治療方法的需求日益成長。隨著定期篩檢和轉診至專科醫生的普及，醫療專業人員越來越傾向於選擇成熟的外科手術來緩解症狀並提高患者的生活品質。這一趨勢推動了外科手術的穩定性、臨床醫生專業技能的提升以及可預測需求模式的形成，所有這些都促進了整體市場成長，並鼓勵對相關醫療保健服務的進一步投資。

全球經經尿道前列腺切除術市場的限制因素

購買和維護手術設備的高昂成本，以及對充足設施的需求，都可能成為經經尿道前列腺切除術服務推廣的重大障礙。不同地區報銷保單的差異進一步加劇了這個問題，因為支付方有限的保險覆蓋範圍對醫療服務提供者造成了經濟負擔。因此，引入和提升手術能力的獎勵降低，最終導致某些市場的可及性受限。這些經濟挑戰阻礙了對培訓和基礎設施的投資，延緩了手術的推廣，並限制了整體市場成長，儘管臨床需求仍然存在。

全球經尿道前列腺切除術（TURP）市場趨勢

隨著醫療機構日益重視改善患者預後和提高手術效率，微創技術的應用正推動經尿道前列腺切除術(TURP) 的全球市場發展。這種向先進手術平台的轉變可縮短恢復時間、減少圍手術全期併發症並加速患者功能恢復。外科醫生致力於研發能夠在組織保留和症狀緩解之間取得有效平衡的創新器械，這促使製造商不斷改進能量傳輸系統和人體工學設計。這一趨勢推動了對臨床醫生培訓和跨學科合作的投入增加，為開發旨在整合工作流程和提高患者生活品質的專用器械組合和夥伴關係關係鋪平了道路。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場公司採取的策略
近期市場趨勢
企業市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 2023-2025年營收年比比較

主要企業簡介

Medtronic
Boston Scientific
Olympus Corporation
Teleflex
KARL STORZ
B. Braun Melsungen AG
Cook Medical
Richard Wolf GmbH
Stryker Corporation
Conmed Corporation
Ethicon
Endo Logic
Merit Medical Systems
PENTAX Medical
Becton Dickinson
Nuvectra Corporation
Apyx Medical
MAXX Medical
Standard Textile
Uroplasty, Inc.

結論與建議

簡介目錄

Product Code: SQMIG35A3229

Global Transurethral Resection Of The Prostate Market size was valued at USD 980.4 Million in 2024 and is poised to grow from USD 1031.38 Million in 2025 to USD 1547.19 Million by 2033, growing at a CAGR of 5.2% during the forecast period (2026-2033).

The market for global transurethral resection of the prostate (TURP) is primarily influenced by demographic shifts towards an aging male population and an increasing prevalence of benign prostatic hyperplasia, driving the demand for surgical solutions. TURP serves as a foundational endoscopic procedure aimed at alleviating urinary obstruction and signifies a standard of care, fostering innovation in related devices. As technology evolved from monopolar to bipolar systems and laser enucleation, the market saw enhanced safety profiles and reduced complications, prompting hospitals to adopt these advancements. Additionally, innovations in energy platforms and perioperative workflows have diminished risks and facilitated quicker recovery times, encouraging widespread clinical adoption. This has led to more procedures being conducted in outpatient settings, allowing manufacturers to offer bundled consumables and expand into emerging markets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transurethral Resection Of The Prostate market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Transurethral Resection Of The Prostate Market Segments Analysis

Global transurethral resection of the prostate market is segmented by product type, technology, application, end user and region. Based on product type, the market is segmented into Monopolar Resectoscope, Bipolar Resectoscope, Laser Instruments and Consumables and Accessories. Based on technology, the market is segmented into Monopolar Technology, Bipolar Technology and Laser Technology. Based on application, the market is segmented into Benign Prostatic Hyperplasia (BPH), Prostate Cancer and Others. Based on end user, the market is segmented into Hospitals, Ambulatory Surgical Centers, Urology Clinics and Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Transurethral Resection Of The Prostate Market

The increasing number of older adults around the world has led to a higher prevalence of benign prostatic hyperplasia and associated urinary issues, driving up the demand for treatment options like transurethral resection of the prostate. As routine screenings and referrals to specialists become more prevalent, healthcare professionals are turning to proven surgical procedures to alleviate symptoms and enhance patients' quality of life. This trend fosters consistent procedural activity, enhances clinician expertise, and establishes predictable demand patterns, all of which contribute to the overall growth of the market and encourage further investment in healthcare services related to these treatments.

Restraints in the Global Transurethral Resection Of The Prostate Market

The high costs linked to acquiring and maintaining surgical equipment, alongside the need for adequate facility provision, can pose significant barriers to the transurethral resection of the prostate services. Variability in reimbursement policies from region to region further complicates matters, as restrictive coverage from payers creates financial obstacles for healthcare providers. This results in reduced incentives to adopt or enhance procedural capabilities, ultimately leading to limited availability in specific markets. Such economic challenges hinder investments in training and infrastructure, decelerate the adoption of procedures, and restrict overall market growth, even in the face of existing clinical demands.

Market Trends of the Global Transurethral Resection Of The Prostate Market

The global market for Transurethral Resection of the Prostate (TURP) is increasingly influenced by the adoption of minimally invasive technologies, as healthcare providers prioritize improved patient outcomes and streamlined procedures. The shift towards these advanced surgical platforms enhances recovery times, minimizes perioperative disruption, and accelerates functional improvements for patients. Surgeons are emphasizing innovative tools that effectively balance tissue preservation with symptom relief, pushing manufacturers to refine energy delivery systems and ergonomic designs. This trend fosters greater investment in clinician training and interdisciplinary collaboration, paving the way for specialized device portfolios and partnerships aimed at integrating workflows and enhancing patient quality of life.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape
Value Chain Analysis

Global Transurethral Resection of The Prostate Market Size by Product Type & CAGR (2026-2033)

Market Overview
Monopolar Resectoscope
Bipolar Resectoscope
Laser Instruments
Consumables and Accessories

Global Transurethral Resection of The Prostate Market Size by Technology & CAGR (2026-2033)

Market Overview
Monopolar Technology
Bipolar Technology
Laser Technology

Global Transurethral Resection of The Prostate Market Size by Application & CAGR (2026-2033)

Market Overview
Benign Prostatic Hyperplasia (BPH)
Prostate Cancer
Others

Global Transurethral Resection of The Prostate Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Ambulatory Surgical Centers
Urology Clinics
Specialty Clinics

Global Transurethral Resection of The Prostate Market Size & CAGR (2026-2033)

North America (Product Type, Technology, Application, End User)
- US
- Canada
Europe (Product Type, Technology, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Technology, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Technology, Application, End User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Technology, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
KARL STORZ
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Richard Wolf GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conmed Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ethicon
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endo Logic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PENTAX Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton Dickinson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nuvectra Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Apyx Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MAXX Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Standard Textile
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Uroplasty, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments